AU Patent

AU2005300559B2 — Method for producing chiral 8-(3-amino-piperidin-1-yl)-xanthines

Assigned to Boehringer Ingelheim International GmbH · Expires 2012-08-02 · 14y expired

What this patent protects

The invention relates to an improved method for producing enantiomer-free 8-(3-amino-piperidin-1-yl)-xanthines.

USPTO Abstract

The invention relates to an improved method for producing enantiomer-free 8-(3-amino-piperidin-1-yl)-xanthines.

Drugs covered by this patent

Patent Metadata

Patent number
AU2005300559B2
Jurisdiction
AU
Classification
—
Expires
2012-08-02
Drug substance claim
No
Drug product claim
No
Assignee
Boehringer Ingelheim International GmbH
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.